MHRA-102198-PIP01-25

Key Facts

Active Substance
Active Substance:
  • Humanized IgG1 monoclonal antibody against thymic stromal lymphopoietin
Invented Name
Not yet available
PIP Number MHRA-102198-PIP01-25
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Solution for injection
Therapeutic area
Therapeutic area:
  • Oto-Rhino-Laryngology
Conditions / Indications
Conditions / Indications:
  • Treatment of nasal polyposis
Route(s) of administration
Route(s) of administration:
  • Subcutaneous use
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Humanized IgG1 monoclonal antibody against thymic stromal lymphopoietin .pdf
Published Date 10/04/2026